Skip to main content
. 2022 Apr 12;18:829–846. doi: 10.2147/NDT.S356341

Table 1.

Reasons for AP-LAI Discontinuation at 6 Month Treatment

Variables Patients Treated with HAL-D (n=37) Patients Treated with PP1M (n=27) Patients Treated with PP3M (n=26) Total (n=90) Statistical Test, Probability
DISCONTINUATION REASONS, n (%)
Patient refusal 0 2 (7.4%) 4 (15.4%) 6 (6.7%) Pearson χ2=26.24 p=0.010
Ineffective treatment 1 (2.7%) 0 0 1 (1.1%)
Side effects 0 1 (3.7%) 0 1 (1.1%)
Medical indications 1 (2.7%) 2 (7.4%) 0 3 (3.3%)
Death 1 (2.7%) 0 0 1 (1.1%)